XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement
3 Months Ended
Mar. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
RESTATEMENT

9. RESTATEMENT

 

On May 22, 2023, the Company filed its Quarterly Report on Form 10-Q for the first quarter of 2023 without the knowledge or review of the Company’s independent auditor, MaloneBailey, LLP. The Company identified the following errors in the Form 10-Q originally filed: 1) an understatement of general and administrative expenses of $28,558; 2) accounting estimates for valuing the stock-based compensation which resulted in an overstatement of general and administrative expenses of $27,952; 3) reclassification of due to related party of $39,423.

 

The following table presents the effects of the restatement on the accompanying balance sheet at March 31, 2023:

 

   As of March 31, 2023 
   As
Previously
Reported
   Restatement
Adjustments
   Restatement
References
  As
Restated
 
Current assets               
Prepaid expense and other current assets  $511   $
-
      $511 
Total current assets   511    
-
       511 
Total assets  $511   $
-
      $511 
                   
LIABILITIES AND STOCKHOLDERS’ DEFICIT                  
Current liabilities:                  
Accrued liabilities  $54,928   $(10,865)  (A) (B)  $44,063 
Due to related party   
-
    39,423   (B)   39,423 
Total current liabilities   54,928    28,558       83,486 
                   
Stockholders’ deficit:                  
Undesignated preferred stock, $0.001 par value, 9,999,942 shares authorized, none issued and outstanding   
-
    
-
       
-
 
Series C convertible non-redeemable preferred stock, $0.001 par value, 48 shares authorized, issued and outstanding at March 31, 2023; $12,500 per share liquidation preference ($600,000 aggregate liquidation preference at March 31, 2023)   
-
    
-
       
-
 
Series D convertible non-redeemable preferred stock, $0.001 par value, 10 shares authorized, issued and outstanding at March 31, 2023; $8,725 per share liquidation preference ($87,250 aggregate liquidation preference at March 31, 2023)   
-
    
-
       
-
 
Common stock, $0.001 par value, 200,000,000 shares authorized, 100,301,968 shares issued and outstanding at March 31, 2023   100,302    
-
       100,302 
Additional paid-in capital   29,350,472    (27,952)  (C)   29,322,475 
Accumulated deficit   (29,505,146)   (606)  (A) (C)   (29,505,752)
Total stockholders’ deficit   (54,417)   (28,558)      (82,975)
Total liabilities and stockholders’ deficit  $511   $
-
      $511 

  

The following table presents the effects of the restatement on the accompanying statement of operation for the three months ended March 31, 2023:

 

   Three Months Ended March 31, 2023 
   As
Previously
Reported
   Restatement
Adjustments
   Restatement
References
  As
Restated
 
Operating expenses               
Stock-based compensation expense   249,654    (27,952)  (C)   221,702 
General and administrative expenses   25,966    28,558   (A)   54,524 
Loss from operations   (275,620)   (606)      (276,226)
                   
Interest expense   
-
    
-
       
-
 
                   
Net loss  $(275,620)  $(606)     $(276,226)
                   
Net loss per share – basic and diluted
  $(0.01)          $(0.01)
                   
Basic and diluted weighted average shares outstanding
   40,581,181            40,581,181 

 

The following table presents the effects of the restatement on the accompanying statement of changes in stockholders’ equity for the three months ended March 31, 2023:

 

           PREFERRED STOCK   ADDITIONAL         
           SERIES C   SERIES D   PAID-IN   ACCUMULATED     
   SHARES   CAPITAL   SHARES   CAPITAL   SHARES   CAPITAL   CAPITAL   DEFICIT   TOTAL 
Balance at March 31, 2023 (As Previously Reported)   100,301,968   $100,302    48   $
       -
    10   $          $29,350,427   $(29,505,146)  $(54,417)
Restatement adjustments   
-
                             (27,952)   (606)   (28,558)
Balance at March 31, 2023 (As Restated)   100,301,968   $100,302    48   $
-
    10   $   $29,322,475   $(29,505,752)  $(82,975)

 

The following table presents the effects of the restatement on the accompanying statement of cash flows for the three months ended March 31, 2023:

 

   As Previously Reported   Restatement
Adjustments
   As Restated 
Net loss  $(275,620)  $(606)  $(276,226)
Stock-based compensation   249,654    (27,952)   221,702 
Accrued liabilities   25,966    28,558    54,524 
                
Non-cash transactions:            
Operating expenses directly paid by a related party  $
-
   $39,423   $39,423 

 

(A)To record professional fee of $28,558.

 

(B)To present professional fee paid by a related party of $39,423 as due to related party.

 

(C)To correct over-recorded stock-based compensation expense by $27,952.